Pharmafile Logo
Pharmafocus logo
Advanced Search

flibanserin

Showing 4 posts of 4 posts found.

Sprout sign

‘Female Viagra’ goes on sale in the US

October 20, 2015
Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder

The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …

News
Sprout sign

Valeant confirms $1bn deal for ‘female viagra’ creator Sprout

August 20, 2015
Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin

Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …

News
Sprout sign

FDA approves ‘female viagra’

August 19, 2015
Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder

The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …

News
Sprout image

FDA to assess female libido drug

June 4, 2015
Sales and Marketing FDA, Sprout Pharmaceutical, flibanserin, libido

The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024